Widespread expression of α-synuclein and τ immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course

Journal of the Neurological Sciences

Volumn 177, Issue 1, 2000, Pages 48-59

  Saito, Yuko ^a,b   Kawai, Mitsuru ^b   Inoue, Kiyoharu ^c   Sasaki, Ryogen ^d   Arai, Hiroyuki ^e   Nanba, Eiji ^f   Kuzuhara, Shigeki ^d   Ihara, Yasuo ^a   Kanazawa, Ichiro ^a   Murayama, Shigeo ^g  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SHIMOSHIZU HOSPITAL   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MIE UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOTTORI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Synuclein; Lewy body; Neuroaxonal dystrophy; Neurofibrillary tangle; Tau

Indexed keywords

ALPHA SYNUCLEIN; TAU INTERFERON;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HALLEVORDEN SPATZ SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL;

ADULT; ALPHA-SYNUCLEIN; CONSANGUINITY; FATAL OUTCOME; FEMALE; HALLERVORDEN-SPATZ SYNDROME; HUMANS; LEWY BODIES; MALE; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; PEDIGREE; SYNUCLEINS; TAU PROTEINS;

EID: 0034253913     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00337-3     Document Type: Article

References (46)

1. Hallervorden J., Spatz H. Eigenartige Erkrankung im extrapyramidalen system mit besondere Beteilgung des Globus pallidus und der Substantia nigra. Ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren. Z. Ges. Neurol. Psychiat. 79:1922;254-302.
2. Yanagisawa N., Shiraki H., Minakawa M., Narabayashi H. Clinico-pathological and histochemical studies of Hallervorden-Spatz disease with torsion dystonia with special reference to diagnostic criteria of the disease from the clinico-pathological viewpoint. Prog Brain Res. 21B:1966;373-425.
3. Dreese M.J., Netsky M.G. Degenerative disorders of the basal ganglia. Minckler J, Bailey OJ, Feigin I, Jervis G, Lindenberg R, Neubuerger KT. Pathology of the nervous system. Vol. 1:1968;1185-1204 McGraw-Hill, New York.
4. Dooling E.C., Schoene W.C., Richardson E.P. Jr. Hallervorden-Spatz syndrome. Arch Neurol. 30:1974;70-83.
5. Sethi K.D., Adams R.J., Loring D.W., el Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol. 24:1988;692-694.
6. Taylor T.D., Litt M., Kramer P., et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet. 14:1996;479-481.
7. Takada K. Early occurrence of Alzheimer's neurofibrillary tangles (NFT) in developmental brain damage and chronic brain disease with early childhood onset. Neuropathology. 13:1993;333-335.
8. Yamazaki M., Tsuganesawa T., Kitamura S., et al. An autopsy case of 21-year clinical course Hallervorden-Spatz disease with minimal deposition of iron particles in the substantia nigra. Neuropathology. 16:(suppl.):1996;100.
9. Sakata C., Katayama S., Inoue K., et al. A case of adult onset Hallervorden-Spatz syndrome with NFTs and Lewy bodies. Neuropathology. 14:(suppl.):1994;143.
10. Wakabayashi K., Fukushima T., Koide R., et al. An autopsy case of juvenile form of generalized neuroaxonal dystrophy with neurofibrillary and Lewy body pathology. Neuropathology (Suppl). 19:1999;206.
11. Grogan T.M., Rangel C., Rimsza L., et al. Kinetic-mode, automated double-labeled immunohistochemistry and in situ hybridization in diagnostic pathology. Adv Pathol Lab Med. 8:1995;79-100.
12. Baba M., Nakajo S., Tu P.H., et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol. 152:1998;879-884.
13. Wenham P.R., Price W.H., Blandell G. Apolipoprotein E genotyping by one-stage PCR [letter]. Lancet. 337:1991;1158-1159.
14. Arawaka S., Saito Y., Murayama S., Mori H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology. 51:1998;887-889.
15. Gilman S., Barrett R.E. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Clinical characteristics and nosological considerations. J Neurol Sci. 19:1973;189-205.
16. Defendini R., Markesbery W.R., Mastri A.R., Duffy P.E. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology. J Neurol Sci. 20:1973;7-23.
17. Williamson K., Sima A.A., Curry B., Ludwin S.K. Neuroaxonal dystrophy in young adults: a clinicopathological study of two unrelated cases. Ann Neurol. 11:1982;335-343.
18. Gaytan-Garcia S., Kaufmann J.C., Young G.B. Adult onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? A clinico-pathological study. Clin Neuropathol. 9:1990;136-142.
19. Rozdilsky B., Bolton C.F., Takeda M. Neuroaxonal dystrophy. A case of delayed onset and protracted course. Acta Neuropathol. 17:1971;331-340.
20. Hayashi S., Akasaki Y., Morimura Y., Takauchi S., Sato M., Miyoshi K. An autopsy case of late infantile and juvenile neuroaxonal dystrophy with diffuse Lewy bodies and neurofibrillary tangles. Clin Neuropathol. 11:1992;1-5.
21. Tuite P.J., Provias J.P., Lang A.E. Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease, and some pathological features of Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry. 61:1996;523-527.
22. Eidelberg D., Sotrel A., Joachim C., et al. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain. 110:1987;993-1013.
23. Wisniewski K., Jervis G.A., Moretz R.C., Wisniewski H.M. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol. 5:1979;288-294.
24. Jellinger K.A., Bancher C. Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol. 8:1998;367-376.
25. Vermersch P., Sergeant N., Ruchoux M.M., et al. Specific tau variants in the brains of patients with myotonic dystrophy. Neurology. 47:1996;711-717.
26. Suzuki K., Parker C.C., Pentchev P.G., et al. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. 89:1995;227-238.
27. Hutton M., Lendon C.L., Rizzu P., et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
28. Higgins J.J., Adler R.L., Loveless J.M. Mutational analysis of the ta gene in progressive supranuclear palsy. Neurology. 53:1999;1421-1424.
29. McKeith I.G., Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47:1996;1113-1124.
30. Hansen L.A., Masliah E., Terry R.D., Mirra S.S. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol. 78:1989;194-201.
31. Seitelberger F. Neuroaxonal dystrophy: its relation to aging and neurological diseases. Vinken P.J., Bruyn G.W., Klawans HL. Handbook of clinical neurology. 1986;Elsevier, Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo.
32. Brucher J.M., Dom R., Robin A. Juvenile spongious degeneration of the central nervous system. Its relation to Hallervorden-Spatz disease and the neuro-axonal dystrophies. Rev Neurol (Paris). 119:1968;425-444.
33. Tomonaga M. Neurofibrillary tangles and Lewy bodies in the locus ceruleus neurons of the aged brain. Acta Neuropathol. 53:1981;165-168.
34. Iseki E., Marui W., Kosaka K., Ueda K. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett. 265:1999;9-12.
35. Fuse S., Inoue K., Iwata M., Mannen T., Toyokura Y. An autopsy case of Hallervorden-Spatz disease with protracted course of about 30 years. Shinkeinaika (Tokyo). 27:1987;155-167.
36. Tennison M.B., Bouldin T.W., Whaley R.A. Mineralization of the basal ganglia detected by CT in Hallervorden-Spatz syndrome. Neurology. 38:1988;154-155.
37. Hartmann H.A., White S.K., Levine R.L. Neuroaxonal dystrophy with neuromelanin deposition, neurofibrillary tangles, and neuronal loss. Light- and electron-microscopic changes in a 45-year-old woman with progressive psychomotor deterioration. Acta Neuropathol. 61:1983;169-172.
38. Alberca R., Rafel E., Chinchon I., Vadillo J., Navarro A. Late onset parkinsonian syndrome in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry. 50:1987;1665-1668.
39. Sugiyama H., Hainfellner J.A., Schmid-Siegel B., Budka H. Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin Neuropathol. 12:1993;147-152.
40. Halliday W. The nosology of Hallervorden-Spatz disease. J Neurol Sci. 134:(Suppl):1995;84-91.
41. Bornstein B., Sandbank U., Fried Y. Hallervorden-Spatz disease associated with Lewy type inclusions. Confin Neurol. 27:1966;397-405.
42. Neumann M., Adler S., Benecke R., Kretzschmar H.A. Juvenile alpha-synucleinopathy. Acta Neuropathol. 98:1999;542.
43. Chichibu M., Oyake Y., Murone I. Autopsy case of Hallervorden-Spatz syndrome with Lewy body. Shinkei Kenkyu No Shimpo. 10:1966;700-707.
44. Vuia O. Neuroaxonal dystrophy, a juvenile-adult form. Clin Neurol Neurosurg. 79:1977;305-315.
45. Park B.E., Netsky M.G., Betsill W.L. Jr. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders. Neurology. 25:1975;1172-1178.
46. Antoine J.C., Tommasi M., Chalumeau A., Jouvet-Telinge A., Bourrat C. Hallervorden-Spatz disease with Lewy bodies. Rev Neurol. 141:1985;806-809.